Abstract:Background Syphilis is a complex systemic disease caused by a spirochete, Treponema pallidum. The World Health Organization estimates that at least 12 million people worldwide are currently infected with syphilis. In this review we compared two current standards of treatment for early syphilis, benzathine benzylpenicillin (penicillin G) and azithromycin. Objectives To evaluate the efficacy and safety of azithromycin versus benzathine penicillin (penicillin G) for early syphilis. Search methods We searched the following databases using the search terms detailed in Appendix 1: the Cochrane Sexually Transmitted Diseases Group Specialized Register (July 2011), the Cochrane Central Register of Controlled Trials (CENTRAL) published in The Cochrane Library (Issue 7 2011), MEDLINE (1948 to July 2011), EMBASE (1980 to July 2011), PsycINFO (1806 to July 2011) and the Chinese Biological Medicine Literature Database (CBM) (1978 to 2011). The search was not limited by language. Selection criteria Randomized controlled trials comparing azithromycin with benzathine penicillin G at any dose for the treatment of early syphilis. Data collection and analysis Two review authors independently applied the inclusion criteria to potential studies, with any disagreements resolved by discussion. The risk of bias of each study was assessed by the same two review authors. We pooled data using an odds ratio (OR). Main results Three studies (generating four eligible study comparisons) were included. One study is ongoing. There was no statistically significant difference between azithromycin and benzathine penicillin treatment in the odds of cure (OR 1.04, 95% CI 0.69 to 1.56); nor any difference at three months (OR 0.97, 95% CI 0.62 to 1.50), six months (OR 1.09, 95% CI 0.76 to 1.54) or nine months (OR 1.45, 95% CI 0.46 to 6.42). Subgroup analysis by primary and latent syphilis and by dose of azithromycin (2 g and 4 g) did not explain the variation between the study results. The reporting of computed mild to tolerated adverse events, from two included trials, indicated no statistically significant difference between azithromycin and benzathine penicillin (OR 1.43, 95% CI 0.42 to 4.95), although with a high level of heterogeneity (P = 0.05, I2 = 74%). Authors' conclusions Differences in the odds of cure did not reach statistical significance when azithromycin was compared with benzathine penicillin for the treatment of early syphilis. No definitive conclusion can be made regarding the relative safety of benzathine penicillin G and azithromycin for early syphilis. Further studies on the utility of benzathine penicillin G for early syphilis are warranted.

Effect of Procaine Benzylpenicillin on Early Syphilis

The effect of syphilis treatment during pregnancy on serological test results in infants born to syphilis mothers

Effectiveness of Treatment to Improve Pregnancy Outcomes among Women with Syphilis in Zhejiang Province, China

Efficacy of minocycline in the treatment of early syphilis

The treatment effect of different subgingival flushing in extrasyphilitic periodontitis

Acute Monoarthritis in a Delayed Diagnosis of Syphilis Patient with Persistent Rupioid Psoriasis-Like Lesions

Azithromycin Versus Penicillin G Benzathine for Early Syphilis

Study on the Prognosis of Early Symptomatic Syphilis

Clinical effect of benzathine benzylpenicillin and azithromycin in the treatment for syphilis during pregnan-cy to prevent congenital syphilis

A Multicenter Study Evaluating Ceftriaxone and Benzathine Penicillin G as Treatment Agents for Early Syphilis in Jiangsu, China

Effect of unintended short-term 3.0 g/day amoxicillin and probenecid treatment for early syphilis on patients with HIV-1 infection

Azithromycin Vs. Benzathine Penicillin G for Early Syphilis: a Meta-Analysis of Randomized Clinical Trials

Nursing Effects of Modified Intramuscular Injection Technique in Syphilis Treatment with Benzathine Penicillin

A 4-fold or greater decrease in TPPA titers may indicate effective BPG treatment in primary syphilis

P3-S6.02 Is fourfold drop of the nontreponemal antibody titrestitres at three or 6 months after early syphilis treatment an effectiveness “criterion?”

Clinical efficacy and tolerability of 1.5 g/day oral amoxicillin therapy without probenecid for the treatment of syphilis

Clinical trial protocol to evaluate the efficacy of cefixime in the treatment of early syphilis

A Randomized, Comparative Pilot Study of Azithromycin Versus Benzathine Penicillin G for Treatment of Early Syphilis

Retrospective Study of 772 Pregnant Women on the Effectiveness of Mother-to-child Transmission-blocking of Syphilis

One Dose versus Three Weekly Doses of Benzathine Penicillin G for Patients Co-Infected with HIV and Early Syphilis: A Multicenter, Prospective Observational Study

Syphilis Treatment: Systematic Review and Meta-Analysis Investigating Non-Penicillin Therapeutic Strategies